These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32077150)

  • 1. MicroRNA-497/fibroblast growth factor-23 axis, a predictive indictor for decreased major adverse cardiac and cerebral event risk in end-stage renal disease patients who underwent continuous ambulatory peritoneal dialysis.
    Liu D; Zhou S; Mao H
    J Clin Lab Anal; 2020 Jun; 34(6):e23220. PubMed ID: 32077150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor-23 correlates with advanced disease conditions and predicts high risk of major adverse cardiac and cerebral events in end-stage renal disease patients undergoing continuous ambulatory peritoneal dialysis.
    Xu L; Hu X; Chen W
    J Nephrol; 2019 Apr; 32(2):307-314. PubMed ID: 30465136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The occurrence and potential predictive factors of major adverse cardiac and cerebral events in end-stage renal disease patients on continuous ambulatory peritoneal dialysis: A prospective cohort study.
    Yao C; Zhou L; Huang Q
    Medicine (Baltimore); 2021 Mar; 100(10):e24616. PubMed ID: 33725825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of circulating coagulation related microRNAs expressions for major adverse cardiac and cerebral event risk in patients undergoing continuous ambulatory peritoneal dialysis: a cohort study.
    Wang Y; Liu C; Wei W; Chen W
    J Nephrol; 2020 Feb; 33(1):157-165. PubMed ID: 31359371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal change in microRNA-130a expression and its correlation with the risk of developing major adverse cardiovascular and cerebral events in patients undergoing continuous ambulatory peritoneal dialysis.
    Wang H; Xu J; Wu X; Zheng S; Han Y; Ding G
    J Clin Lab Anal; 2021 Dec; 35(12):e24039. PubMed ID: 34708454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of serum omentin-1 level with clinical features and major adverse cardiac and cerebral events in patients undergoing continuous ambulatory peritoneal dialysis.
    Yao C; Ou J; Zhou L; Liu J
    Scand J Clin Lab Invest; 2023 Apr; 83(2):119-124. PubMed ID: 36847753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA NEAT1/microRNA-125a axis predicts increased major adverse cardiac and cerebrovascular event risk independently in patients with unprotected left main coronary artery disease underwent coronary artery bypass grafting.
    Liu H; Yan X; Yu J
    J Clin Lab Anal; 2020 Jul; 34(7):e23299. PubMed ID: 32185824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor-23 and interleukin-6 are risk factors for left ventricular hypertrophy in peritoneal dialysis patients.
    Liu WH; Zhou QL; Ao X; Yu HL; Peng WS; He N
    J Cardiovasc Med (Hagerstown); 2012 Sep; 13(9):565-9. PubMed ID: 22728833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of Circulating Proangiogenic MicroRNAs for Predicting Major Adverse Cardiac and Cerebrovascular Events in Unprotected Left Main Coronary Artery Disease Patients Who Underwent Coronary Artery Bypass Grafting.
    Shen J; Chang C; Ma J; Feng Q
    Cardiology; 2021; 146(3):400-408. PubMed ID: 33730720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemia-modified albumin, a predictive marker of major adverse cardiovascular events in continuous ambulatory peritoneal dialysis patients.
    Su X; Zhang K; Guo F; Yuan B; Wang C; Xiao L; Wang J; Huang H
    Clin Biochem; 2013 Oct; 46(15):1410-3. PubMed ID: 23796881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cardiovascular risk factor profiles among end-stage renal failure patients treated with continuous ambulatory peritoneal dialysis and intermittent hemodialysis.
    Zamiah SAKS; Draman CR; Seman MR; Safhan AF; Rozalina R; Nik Ruzni NI
    Saudi J Kidney Dis Transpl; 2018; 29(1):114-119. PubMed ID: 29456216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory peritoneal dialysis in a Mexican PD center.
    Sanchez AR; Madonia C; Rascon-Pacheco RA
    Kidney Int Suppl; 2008 Apr; (108):S76-80. PubMed ID: 18379553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of plasma amino acid concentrations in end-stage renal disease patients on hemodialysis and peritoneal dialysis.
    Kim DH; Yang DH; Hong SY
    Korean J Intern Med; 1998 Feb; 13(1):33-40. PubMed ID: 9538629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes.
    Satirapoj B; Supasyndh O; Phantana-Angkul P; Ruangkanchanasetr P; Nata N; Chaiprasert A; Kanjanakul I; Choovichian P
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S87-93. PubMed ID: 22043573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selected growth factors in peritoneal dialysis: their relationship to markers of inflammation, dialysis adequacy, residual renal function, and peritoneal membrane transport.
    Stompór T; Zdzienicka A; Motyka M; Dembińska-Kieć A; Davies SJ; Sulowicz W
    Perit Dial Int; 2002; 22(6):670-6. PubMed ID: 12556068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
    Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
    J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-Year Survival Rate of Patients with End-Stage Renal Disease on Continuous Ambulatory Peritoneal Dialysis (CAPD) at Malang CAPD Center, Indonesia.
    Gunawan A; Sakti PT
    Acta Med Indones; 2023 Jan; 55(1):4-9. PubMed ID: 36999264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shortage of Appendicular Skeletal Muscle Is an Independent Risk Factor for Mortality in Peritoneal Dialysis Patients.
    Jin S; Lu Q; Su C; Pang D; Wang T
    Perit Dial Int; 2017 1-2; 37(1):78-84. PubMed ID: 27282855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for cardio-cerebrovascular events among patients undergoing continuous ambulatory peritoneal dialysis and their association with serum magnesium.
    Li P; Lv T; Xu L; Yu W; Lu Y; Li Y; Hao J
    Ren Fail; 2024 Dec; 46(1):2355354. PubMed ID: 38785302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients.
    Wang AY; Lam CW; Wang M; Woo J; Chan IH; Lui SF; Sanderson JE; Li PK
    Am J Kidney Dis; 2005 Apr; 45(4):715-29. PubMed ID: 15806475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.